当前位置: 首页 > 期刊 > 《东南国防医药》 > 2003年第6期
编号:11025842
普米克令舒加溴化异丙托品雾化吸入佐治伴有喘息的婴幼儿肺炎
http://www.100md.com 《东南国防医药》 2003年第6期
小儿肺炎普米克令舒雾化吸入,,]小儿肺炎普米克令舒雾化吸入,[摘要],[关键词],1资料与方法,2结果,3讨论,参考文献
     [摘要]目的探讨普米克令舒加溴化异丙托品雾化吸入佐治小儿肺炎的疗效。方法将同期在我科住院的46例肺炎患儿,随机分为普米克令舒+溴化异丙托品组(简称为普米克组)和对照组,两组均给予相同的综合性治疗,普米克组外加普米克令舒和溴化异丙托品气泵雾化吸入治疗。对治疗前后咳嗽、气喘、哮鸣音、湿口罗音消失及住院时间进行观察比较。结果两组咳嗽及湿口罗音消失时间无显著性差异(P>005),而在气喘缓解、肺部哮鸣音消失及住院时间方面普米克组较对照组有显著性差异(P<001)。结论普米克令舒加溴化异丙托品雾化吸入佐治小儿肺炎疗效确切,安全、操作方便,适用于各年龄段的患儿。值得临床推广应用。

     [关键词]小儿肺炎普米克令舒雾化吸入

    Observation of the effect of pulmicort repules and atrovent solution inhalant nebulized for treating infants with wheezy pneumonia

    TAN Ningning, SUN Yu, GU Jilie, et al. Department of pediatrics, the 81th Hospital of PLA, Nanjing 210002

    [Abstract]ObjectiveTo explore the effect of pulmicort repules and atrovent solution inhalant nebulized for treating infants with wheezy pneumonia. MethodsFortysix patients with wheezy pneumonia were divided randomly into 2 groups (pulmicort repules and atrovent, control). All patients were treated by the same general measures, but the patients in Group (pulmicort repules and atrovent) were nebulized with pulmicort repules and atrovent solution inhalant. Cough, breathless, wheeze, resolution of rale and the duration of being in hospital were analyzed and compared. ResultsThere were no significant differences in the resolution of cough and rale, but significant differences in breathless, wheeze and the duration of being in hospital. Conclusions Pulmicort repules and atrovent solution inhalant is a safe and effective agent nebulized for treating infants with wheezy pneumonia and worth to be recommended. ......

您现在查看是摘要页,全文长 5771 字符